en · de · es · pt
liraglutide-notes.peptides6088.com › Blog › Detection, Regulation, And Quality Context — Practical Notes

Detection, Regulation, And Quality Context — Practical Notes

By Editorial Desk · published 2026-03-18 · last reviewed 2026-04-26 · Blog

A practical reference on GW501516: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-04-26. Anything still debated is marked as such rather than presented as settled.

Detection, Regulation, and Quality Context

Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.

Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.

Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.

Mechanism and Detection Methods

GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.

Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.

Cardarine at a glance

PropertyValueNotes
WADA classificationS4 Hormone and Metabolic ModulatorsProhibited at all times in sport.
Drug approval statusNot approved in major jurisdictionsNo accepted therapeutic indication.
Common detection methodLC-MS/MSDetects parent compound and metabolites.
Typical test matrixUrine or bloodUrine is common in anti-doping testing.
Product labelingResearch chemical or supplementOften not independently verified.

Identity and Pharmacological Mechanism

Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Related pages on this site

Regulation and Analytical Detection

Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.

Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.

Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.

Identity and Regulatory Status

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.

Supporting material

==== Café La Crème shooting ==== In 2017, two masked hitmen fired shots at the Café La Crème in Marrakech, killing Hamza Chaib, a 26-year-old medical student, and injuring two others. A Glock 19 and a motorcycle used by the hitmen to flee were found charred nearby. The hitmen were identified by the Marrakech Prefecture Judicial Police as Shardyone Ulises Girigorio Semerel, a 29-year-old Dutch-Surinamese national, and Edwin Gabriel Robles Martínez, a 24-year-old Dutch-Dominican national. Six other suspects were detained. They were known to Moroccan authorities for their involvement in cases of international drug trafficking, kidnapping, armed robbery, and attempted homicide. Their initial target was the owner of the lounge, Mustapha "Mous" el Fechtali, a member of the Bouyakhrichan clan involved in international money laundering. Moroccan authorities are known to use torture on suspects to gain information, leading to the hitmen quickly pointing out Taghi as their ringleader. The shooting led to a closer collaboration between the Dutch and Moroccan authorities to combat organised crime, especially towards Taghi's organisation. The hitmen were sentenced to death by the Marrakech Court of Appeal in 2019. Mustapha el Fechtali was sentenced to 15 years in jail for drug trafficking. An alleged coordinator, 33-year-old Seddik Rais, was freed after his extradition from the Canary Islands.

2023 Christie G. Enke and Richard Yost for their development of the triple quadrupole mass spectrometer and the tremendous impact triple quads have made for a wide range of biomedical research applications. 2022 Jennifer Lippincott-Schwartz 2020 George Church for his groundbreaking research in genomic sequencing and his leadership in the fields of gene therapy and synthetic biology technologies. 2019 Richard M. Caprioli for the discovery of temporal and spatial processing in biological systems using mass spectrometry. 2018 Amos Bairoch for the development of community resources such as UniProtKB/Swiss-Prot knowledgebase, PROSITE, ENZYME, and neXtProt. 2017 Sir Shankar Balasubramanian and David Klenerman for the invention of a method of next-generation DNA sequencing which is commonly known today as "sequencing by synthesis". 2016 Emmanuelle Charpentier and Jennifer Doudna for the development of CRISPR/Cas9 Genome Editing Technologies. 2015 John G. White and William Bradshaw Amos for the development of high-resolution, laser scanning confocal microscope 2014 Patrick H. O'Farrell, for the development of 2-dimensional gel electrophoresis. 2013 Leonard Herzenberg and Leonore Herzenberg for the development of Flow Activated Cell Sorting (FACS). 2012 Alan G. Marshall for the development of Fourier Transform Ion Cyclotron Resonance (FT-ICR) Mass Spectrometry.

6-Monoacetylmorphine (6-MAM, 6-acetylmorphine, or 6-AM) is an opioid and also one of three active metabolites of heroin (diacetylmorphine), the others being morphine and the much less active 3-monoacetylmorphine (3-MAM).

Sources: en.wikipedia.org

Supporting material

The Earl S. Richardson Library's is the main academic information resource center on the campus. Constructed in 2008, the building covers approximately 222,517 square feet. The library's holding constitutes over 500,000 volumes, and access to over 1 million e-books and 5,000 periodical titles. There are 167 online databases that are subscribed to the Library. Reading and studying spaces are provided with wired and wireless access to databases for research. One such collection in the volumes includes books on Africa, with an emphasis on sub-Saharan Africa. The African-American collection includes papers and memorabilia of such persons as Emmett Jay Scott, secretary to Booker T. Washington. The Forbush Collection is composed of materials associated with the Quakers and slavery. The Martin D. Jenkins Collection was acquired in 1980.

Self-assembling peptides are a category of peptides which undergo spontaneous assembly into ordered nanostructures. Originally described in 1993, these designer peptides have attracted interest in the field of nanotechnology for their potential for application in areas such as biomedical nanotechnology, tissue cell culturing, molecular electronics, and more. Effectively self-assembling peptides act as building blocks for various material and device applications. The essence of this technology is to replicate what nature does: to use molecular recognition processes to form ordered assemblies of building blocks capable of conducting biochemical activities.

Medical uses include treatment of severe anxiety. Despite certain side effects and the emergence of alternative products (e.g., pregabalin), benzodiazepine medication remains an effective way of reducing problematic symptoms, and is typically deemed effective by patients and medical professionals. Similarly to other intermediate-acting depressants, it may be used as hypnotic medication, though prescribing for insomnia is generally limited to a maximum of four weeks due to dependence risks and limited long-term efficacy or in order to mitigate withdrawal effects of alcohol consumption.

=== Biosynthesis === Prostacyclin is produced in endothelial cells, which line the walls of arteries and veins, from prostaglandin H2 (PGH2) by the action of the enzyme prostacyclin synthase. Although prostacyclin is considered an independent mediator, it is called PGI2 (prostaglandin I2) in eicosanoid nomenclature, and is a member of the prostanoids (together with the prostaglandins and thromboxane). PGI2, derived primarily from COX-2 in humans, is the major arachidonate metabolite released from the vascular endothelium. This is a controversial point, some assign COX 1 as the major prostacyclin producing cyclooxygenase in the endothelial cells of the blood vessels. The series-3 prostaglandin PGH3 also follows the prostacyclin synthase pathway, yielding another prostacyclin, PGI3. The unqualified term 'prostacyclin' usually refers to PGI2. PGI2 is derived from the ω-6 arachidonic acid. PGI3 is derived from the ω-3 EPA.

Sources: en.wikipedia.org

Supporting material

In 2012 and 2014, the Aspen Institute named Santa Fe College one of the ten best community colleges in the U.S. In 2015, the college received the Aspen Prize for Community College Excellence, recognizing it as the top community college in the country. In 2015, the Lawrence W. Tyree Library received the Excellence in Academic Libraries Award from the Association of College & Research Libraries.

Spray ionization methods involve the formation of aerosol particles from a liquid solution and the formation of bare ions after solvent evaporation. Solvent-assisted ionization (SAI) is a method in which charged droplets are produced by introducing a solution containing analyte into a heated inlet tube of an atmospheric pressure ionization mass spectrometer. Just as in Electrospray Ionization (ESI), desolvation of the charged droplets produces multiply charged analyte ions. Volatile and nonvolatile compounds are analyzed by SAI, and high voltage is not required to achieve sensitivity comparable to ESI. Application of a voltage to the solution entering the hot inlet through a zero dead volume fitting connected to fused silica tubing produces ESI-like mass spectra, but with higher sensitivity. The inlet tube to the mass spectrometer becomes the ion source.

Phencyclidine (PCP), tenocyclidine (TCP), etoxadrol and its precursor, dexoxadrol have related chemical structures. These drugs all act similarly on the nervous system, acting as dissociative hallucinogens (meaning that they interfere with normal sensory signals, replacing them with hallucinations of any sensory modality!) with anesthetic and analgesic properties.

Sources: en.wikipedia.org

Frequently asked questions

How is cardarine detected in anti-doping tests?

Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.

Is cardarine legal?

Legality varies by country and context. It lacks marketing approval as a medicine in major countries. Sports organizations prohibit its use at all times.

What does a certificate of analysis show?

A certificate of analysis may report identity, purity, and testing methods for a specific batch. It does not guarantee safety or legal status. Independent verification can confirm whether the material matches the label.

What receptor does cardarine target?

Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.

Network